Amiodarone

Amiodarone, Cordarone, Nexterone (amiodarone) is a small molecule pharmaceutical. Amiodarone was first approved as Amiodarone on 1985-12-24. It is used to treat cardiac arrhythmias, supraventricular tachycardia, and ventricular fibrillation in the USA. It is known to target potassium voltage-gated channel subfamily A member 7, muscarinic acetylcholine receptor M5, sodium channel protein type 5 subunit alpha, and NAD-dependent protein deacetylase sirtuin-3, mitochondrial. Amiodarone hydrochloride's patent is valid until 2029-03-13 (FDA).